How to Screen Stocks Like Warren Buffett: A Two-Part Framework That Actually Works

The Oracle’s Timeless Wisdom

Warren Buffett may have stepped down as CEO of Berkshire Hathaway, but his investment philosophy continues to guide market participants. In his 2013 shareholder letter, Buffett outlined a deceptively simple yet ruthlessly effective method for evaluating whether to buy into any stock. As markets enter 2026, this framework deserves fresh attention—especially when selectivity matters more than ever.

The formula Buffett and his partner Charlie Munger developed cuts through market noise by asking two fundamental questions. It’s not about predicting the future perfectly. It’s about being honest about what you actually understand.

Part One: Can You Forecast the Business?

Here’s where most investors stumble. Buffett’s first test demands a critical capability: the ability to sensibly estimate a company’s earnings for the next five years or longer. Notice the word “sensibly.” He’s not talking about random guesses or extrapolating past performance blindly.

This requires staying within your zone of expertise. If you understand pharmaceuticals, healthcare infrastructure, or industrial metals, you’re closer to making a sound projection. If you don’t—if you’re evaluating a company in an unfamiliar industry—Buffett’s advice is simple: walk away to the next opportunity.

The reason is practical. When you lack domain knowledge, you’ll likely miss critical industry trends, competitive shifts, or regulatory changes that could derail earnings. Buffett himself admits he made mistakes even within his circle of competence. The average investor will make far more.

Part Two: Is the Price Right?

If you pass the first hurdle, the second becomes crucial: checking whether the stock’s valuation aligns with your earnings projection. Here’s Buffett’s edge—he doesn’t use optimistic projections. He values the stock against the lower boundary of his estimated earnings range. This margin of safety protects you when reality disappoints.

Why This Matters Now

Buffett has been a net seller of stocks for twelve consecutive quarters and maintains a record cash position at Berkshire. He’s applying his own framework ruthlessly. The market has fewer candidates that pass his test—and that’s information worth paying attention to.

Real Examples: Stocks Meeting the Standard

Two stocks currently align with Buffett’s criteria:

AbbVie (NYSE: ABBV) demonstrates clear visibility. The pharmaceutical giant successfully navigated the Humira patent cliff—a major industry hurdle. Its revenue streams appear stable and predictable over the next five years, with robust earnings growth potential. Valuation remains reasonable. The company also offers a 3% forward dividend yield and belongs to the Dividend Kings—firms that have raised dividends for 50+ consecutive years. This business is understandable and fairly priced.

Nucor (NYSE: NUE) shows another angle. The steelmaker benefits from two tailwinds: surging data center construction and U.S. infrastructure investment cycles. A forward P/E ratio of 14.5 appears attractive relative to its five-year growth prospects. Again, you can model this business with reasonable confidence, and the price reflects that opportunity.

The Real Challenge

Buffett’s framework is intellectually simple but practically demanding. The bottleneck isn’t the framework itself—it’s your ability to accurately forecast earnings. This demands genuine expertise, intellectual humility, and willingness to skip opportunities you don’t understand.

Most investors fail at step one. They either overestimate their predictive abilities or lack the discipline to admit ignorance. Those who succeed at the Buffett approach tend to outperform those chasing trendy sectors they barely comprehend.

As 2026 unfolds, consider whether your stock picks can pass both tests. If you can’t confidently project five years of earnings using knowledge you genuinely possess—and if the price doesn’t offer a margin of safety—Buffett’s advice remains timeless: move on.